Rethinking How Asia Pays for Health: From Volume to Value

Rising medical bills across Asia are exposing deep weaknesses in how healthcare is financed and delivered. An ageing population, the surge in chronic illnesses, and the adoption of more sophisticated – and expensive – therapies are pushing public and private budgets to the limit. Existing payment structures, which depend heavily on out-of-pocket spending and fragmented insurance arrangements, are increasingly unable to shield patients from financial strain or to incentivise better long-term outcomes. Without a systematic redesign of financing and reimbursement, millions risk catastrophic expenses while health systems struggle to maintain quality and access.

Why fee-for-service is no longer fit for purpose

The conventional fee-for-service approach – sometimes described as volume-based reimbursement – rewards volume: more tests, consultations and procedures mean higher revenue. That creates perverse incentives when the health burden shifts toward conditions that require continuity of care and prevention, such as diabetes, cardiovascular disease and dementia. In those cases, episodic, high-intensity interventions do little to prevent deterioration and may even accelerate overall costs.

Think of the system like paying mechanics by the number of repairs completed rather than by how long a vehicle remains roadworthy; you end up encouraging frequent fixes instead of durable solutions. Governments from Japan to Thailand are already confronting this reality and trialling models that tie funding to measurable outcomes and entire care pathways rather than itemised billables.

The demographic and fiscal pressure

Asia’s demographic shift is sharp and fast. Several markets already have substantial elderly populations – Japan, for example, has roughly 29% of its residents aged 65 and over – while other economies such as South Korea and Singapore are aging rapidly. Health budgets are being squeezed as the prevalence of long-term conditions rises and utilization patterns shift toward recurrent outpatient visits and long-term care. Analysts warn there is only a limited window to change incentives before spending trajectories become much harder to bend.

Alternatives on the table: bundled payments, capitation and outcome-based contracts

Policy experts are promoting a move toward payment approaches that reward results and efficient management of episodes of care. Key mechanisms gaining traction include:

• Bundled payments that fund a full treatment pathway – for example, joint replacement surgery plus rehabilitation – rather than isolated procedures;
• Capitation models that provide a fixed per-patient payment to manage all or most primary care needs over a period;
• Outcome-based contracts that link a share of provider or insurer revenue to agreed quality and health indicators, such as readmission rates or long-term disease control.

Early pilots across the region suggest these approaches can simultaneously curb wasteful overuse and improve patient experience, but success depends on credible, risk-adjusted metrics and the ability to measure outcomes over months and years, not just discrete encounters.

Priority shifts for policymakers

Regional briefings identify a handful of immediate priorities:

• Realign incentives so providers are rewarded for prevention, disease management and patient satisfaction rather than volume;
• Preserve fiscal space by reducing low-value imaging, inappropriate prescribing and avoidable admissions;
• Build interoperable data systems that can link episodes of care across public and private sectors;
• Protect equity so older and lower-income groups are not disproportionately exposed to out-of-pocket shocks.

Measuring success: what outcome-based financing looks like in practice

Under outcome-driven schemes, a proportion of hospital or insurer revenue is contingent on meeting agreed targets – for instance, lower 30-day readmission rates, improved blood-sugar control among diabetic cohorts, or patient-reported improvement in daily functioning. Providers that consistently meet benchmarks can earn higher payments, while underperformers face lower tariffs or phased penalties. To be fair and effective, targets must be risk-adjusted and accompanied by transition periods that let institutions invest in data platforms, staff training and preventive services.

Pilot programmes in several Asian markets already incorporate elements such as shared-savings arrangements (splitting efficiency gains between payers and providers) and patient-reported outcome measures (PROMs) included in reimbursement formulas. Early results indicate reduced overall spending growth and improved continuity of care in targeted patient groups.

Digital claims, primary care and public-private cooperation: the operational roadmap

Beyond payment reform, the report highlights three operational levers that can materially contain costs and improve service delivery:

• Digital claims integration: Implementing real-time e-claims and interoperable health-data standards reduces administrative waste, combats fraud and shortens payment cycles. Automated eligibility checks and AI-assisted claims review have cut adjudication times in pilots from weeks to days, enabling payers and providers to reallocate savings toward care improvement.
• Stronger primary care: Investing in first-contact services and primary care networks shifts management of chronic disease away from costly hospital settings. Capitated arrangements or bundled payments at the primary-care level incentivise prevention and early intervention.
• Public-private partnerships: Strategic consortia can expand capacity at predictable prices by sharing infrastructure, clinical protocols and data, particularly where public systems face resource constraints.

These interventions have different timelines: digital claims upgrades can show benefits within 1-3 years; strengthening primary care typically requires 3-5 years to materially reduce hospitalisations; and durable public-private collaborations are an ongoing effort over five years or more.

A snapshot of ageing and policy signals in selected markets

Latest national estimates (2023 or most recent year) show markedly different demographic pressures and policy responses across the region:

• Japan – 65+ approx. 29%: piloting bundled payments for chronic care;
• South Korea – 65+ approx. 18%: expanding value-based purchasing;
• Singapore – 65+ approx. 16%: introducing capitation in primary care networks;
• Thailand – 65+ approx. 13%: testing global hospital budgets.

What success will require

Transitioning from volume-driven to value-oriented financing is a technical and political challenge. It demands a shared set of metrics, transparent reporting, stronger digital infrastructure and time-limited transition arrangements so providers can adapt. Policymakers must also safeguard vulnerable populations during the shift to ensure reforms do not inadvertently raise out-of-pocket burdens.

If regulators, payers and providers can coordinate on new reimbursement frameworks, data-sharing standards and incentives that prioritise long-term health, Asia’s health systems stand a chance of remaining both solvent and accessible. The alternative – piecemeal tinkering that leaves fee-for-service structures intact – risks turning an affordability problem into a systemic crisis.

Final thoughts

The question is no longer whether healthcare financing in Asia must evolve, but how quickly and comprehensively it will do so. With demographic headwinds and medical innovation continuing to raise costs, the time for bold, coordinated reform is now. Successful examples from regional pilots offer blueprints, but scaling them will require political will, sustained investment in data and workforce, and patient-centred accountability.